Transcriptomics

Dataset Information

0

Expression data from ovarian cancer cell line OVCAR3 following Knockdown or Knockout of BORIS (CTCFL)


ABSTRACT: The identification of prognostic biomarkers is a priority for patients suffering from high-grade serous ovarian cancer (SOC), which accounts for >70% of ovarian cancer (OC) deaths. Meanwhile borderline ovarian cancer (BOC) is a low malignancy tumor and usually patients undergo surgery with low probabilities of recurrence. However, SOC remains the most lethal neoplasm due to the lack of biomarkers for early diagnosis and prognosis. In this regard BORIS (CTCFL), a CTCF paralog, is a promising cancer biomarker that is overexpressed and controls transcription in several cancer types, mainly in OC. Studies suggest that BORIS has an important function in OC by altering gene expression, but the effect and extent to which BORIS influences transcription in OC from a genome-wide perspective is unclear. Here we sought to identify BORIS target genes in an OC cell line (OVCAR3) with potential biomarker use in OC tumor samples. To achieve this, we performed in vitro knockout (KO) and knockdown (KD) experiments of BORIS in OVCAR3 cell line followed by expression microarrays and bioinformatics network enrichment analysis to identify relevant BORIS target genes.

ORGANISM(S): Homo sapiens

PROVIDER: GSE130163 | GEO | 2019/07/31

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-01-11 | GSE213611 | GEO
2018-11-04 | GSE122123 | GEO
| PRJNA534124 | ENA
2022-08-03 | GSE200641 | GEO
2020-03-06 | GSE127873 | GEO
2024-09-02 | BIOMD0000000741 | BioModels
2020-09-30 | GSE144948 | GEO
2013-05-01 | E-GEOD-43029 | biostudies-arrayexpress
2019-10-10 | GSE112985 | GEO
2021-06-07 | PXD023508 | Pride